Crinetics Pharmaceuticals, Inc. Current Liabilities
Crinetics Pharmaceuticals, Inc. (CRNX) had Current Liabilities of $79.92 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-03
- 2026-06-30: Liabilities, Current $79.92M.
- 2026-03-31: Liabilities, Current $71.09M.
- 2025-12-31: Liabilities, Current $85.07M.
- 2025-09-30: Liabilities, Current $74.16M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $79.92M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $71.09M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $85.07M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $74.16M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $68.40M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $57.31M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $59.68M 10-K · filed 2026-02-26 |
| 2024-09-30 | $53.56M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $54.38M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $51.77M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $43.94M 10-K · filed 2025-02-27 |
| 2023-09-30 | $40.46M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $32.61M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $26.32M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $27.72M 10-K · filed 2024-02-28 |
| 2022-09-30 | $24.56M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $26.11M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $20.26M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $15.99M 10-K · filed 2023-02-28 |
| 2021-09-30 | $12.44M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $11.92M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $10.26M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.49M 10-K · filed 2022-03-30 |
| 2020-09-30 | $8.83M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $9.87M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $10.76M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $8.34M 10-K · filed 2021-03-30 |
| 2019-09-30 | $7.88M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $7.75M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $8.82M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $7.92M 10-K · filed 2020-03-09 |
| 2018-09-30 | $5.51M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $5.64M 10-Q · filed 2018-08-30 |
| 2017-12-31 | $897.00K 10-K · filed 2019-03-13 |